Research On The Development Strategy Of Shenzhen International Institute For Biomedical Research

Biological and life health industries have always been the industries strongly supported by national industrial policies.They are important symbols reflecting the overall strength of a country or region's economy and the level of scientific and technological development.They are also one of the key areas of strategic emerging industries that China is accelerating the implementation of.With the vigorous development of biological and life health industries,China's biomedical industry has also developed rapidly.As A Research Institute in the field of biomedicine,Shenzhen International Institute For Biomedical Research was approved by the Shenzhen Municipal Government in 2015 and co-sponsored and established by the professor team of American universities and local scientists.Since the establishment of Shenzhen International Institute For Biomedical Research,it has been established.Although some research results have been achieved,However,there are still some problems,such as insufficient R&D funds,weak ability to transform R&D achievements,low enthusiasm for job title declaration and lack of flexibility in operation and management mode.In order to achieve further development,Shenzhen International Institute For Biomedical Research needs to position and upgrade its own development strategy.Based on this,this paper will study the development strategy of Shenzhen International Institute For Biomedical Research under the new environment.Based on the theory of enterprise strategic management,this study used PEST analysis and Porter's five-force model to analyze the internal and external environment of Shenzhen International Institute For Biomedical Research.The SWOT analysis method was used to systematically put forward the development strategy of Shenzhen International Institute For Biomedical Research,i.e.forward-forward integrated-backward strategy,which will make the Institute a first-class biomedical research and development institution in Guangdong,Hong Kong and Macao.By creating first-class research and development institutions of biomedicine,we incubate the leading domestic biomedicine high-tech enterprises of biomedicine technology,and build an integrated industrial chain of biomedicine.The implementation of the strategy mainly includes the following four ways: first,to actively promote the construction of biomedical transformation base in Dawan District of Rozmann and build biomedical industry chain;second,to "one-stop" incubation and transformation platform to enhance the success rate of transformation of scientific research results;third,to actively carry out research on biomedical original projects with hot foreword,and enrich the advantages of project resources;fourth,to enter the company;Provide one-stop supporting services.Finally,this study puts forward the strategic implementation safeguards of Shenzhen International Institute For Biomedical Research from the following five aspects: firstly,strictly screen the projects in the research institute to improve the success rate of project transformation;secondly,establish an effective salary system and incentive system to enhance the enthusiasm of young backbone Title selection;thirdly,optimize the structure of human resources and set up a professional service team of biomedicine incubator;fourthly,increase research and development investment and enhance the research and development capacity of the research institute;It is to strengthen the financial management of the Research Institute and actively broaden the financing channels of the research institute.